Abstract
The surgical treatment of colon cancer in elderly patients (aged 70 years or older) has improved, but data on adjuvant and palliative chemotherapy tolerability and benefits in this growing population remain scarce. Elderly patients are under-represented in clinical trials and results for older patients are seldom reported separately. However, elderly patients with good performance status tolerate adjuvant and palliative chemotherapy for colon cancer as well as their younger patients, and have similar benefits from palliative chemotherapy. This article examines the factors pertinent to the small number of trials designed for colon cancer in this group of persons.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
